Rosen & Barkin's 5-Minute Emergency Medicine Consult (457 page)

Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
7.83Mb size Format: txt, pdf, ePub
MEDICATION
  • Activated charcoal: 1–2 g/kg PO
  • Cyproheptadine: 4–8 mg PO/nasogastric tube q1–4h until therapeutic response; max. daily dose: 0.5 mg/kg (peds: 0.25 mg/kg/d; max. 12 mg/d; safety not established age <2 yr)
  • Dextrose: D50W 1–2 amp (50–100 mL or 25–50 g) (peds: D25W 2–4 mL/kg) IV push (IVP)
  • Diazepam: 5–10 mg (peds: 0.1 mg/kg slowly) increments IVP
  • Lorazepam: 1–2 mg increments IVP
  • Nitroprusside: 0.3–10 μ/kg/min IV
  • Norepinephrine: 2-4 μ/kg/min (peds: 0.05–0.1 μ/kg/min) IV
  • Phentolamine: 5 mg (peds: 0.05–0.2 mg/kg/dose) increments IVP
  • Sodium bicarbonate: Bolus 1–2 mEq/kg IVP; adult infusion: 3 amp (50 mEq per amp) sodium bicarbonate in 1,000 mL D5W at 2–3 mL/kg/h IV
  • Vecuronium: 0.1 mg/kg IVP
FOLLOW-UP
DISPOSITION
ALERT

MAOI toxicity can occur in delayed fashion necessitating an extended observation period

Admission Criteria
  • All MAOI overdose patients require admission to a monitored unit for 24 hr.
  • ICU admission for seriously ill patients
Discharge Criteria
  • Resolved mild hypertensive syndrome or resolved mild serotonin syndrome may be discharged after several hours of ED observation.
Issues for Referral

Intentional overdoses should receive a psychiatry consult for suicide attempt.

FOLLOW-UP RECOMMENDATIONS

Following significant MAOI toxicity, medications need to be reassessed to prevent future crises.

PEARLS AND PITFALLS
  • Delayed onset of 6–12 hr prior to symptoms
  • Linezolid and methylene blue are MAOIs.
  • Phentolamine is contraindicated in MAOI overdose secondary to unopposed β-agonist.
ADDITIONAL READING
  • Boyer EW, Shannon M. The serotonin syndrome.
    New Engl J Med
    . 2005;352:1112–1120.
  • Brush DE, Bird SB, Boyer EW. Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances.
    J Toxicol Clin Toxicol
    . 2004;42:191–195.
  • Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.
    Br J Anaesth
    . 2005;95:434–441.
  • Oates JA, Sjoerdsma A. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor.
    Neurology
    . 1960;10:1076–1078.
  • Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: Inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.
    Br J Pharmacol
    . 2007;152:946–951.
See Also (Topic, Algorithm, Electronic Media Element)

Sympathomimetic Poisoning

CODES
ICD9

969.01 Poisoning by monoamine oxidase inhibitors

ICD10
  • T43.1X1A Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
  • T43.1X2A Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
  • T43.1X4A Poisoning by MAO inhib antidepressants, undetermined, init
MONONUCLEOSIS
Steven C. Rogers

Alberto Cohen-Abbo
BASICS
DESCRIPTION
  • Results in most cases from infection with the Epstein–Barr virus (EBV) (a herpesvirus):
    • Non-EBV causes of infectious mononucleosis (IM):
      • Cytomegalovirus (CMV)
      • Adenovirus
      • Hepatitis A
      • Herpesvirus 6
      • HIV
      • Rubella
      • Toxoplasma gondii
      • Group A β-hemolytic streptococci
  • >90% of adults on serologic testing demonstrate prior infection with EBV:
    • Most do not recollect specific IM symptoms
  • Mode of transmission is close or intimate contact particularly with saliva from “shedders” who may or may not be symptomatic:
    • Nickname “kissing disease”
    • Viral shedding in saliva can persist intermittently for life
    • May occur after transfusions/transplants
  • Incubation period: 4–6 wk
  • Immunologic response:
    • T-cells response:
      • T-cell response is responsible for an elevated absolute lymphocyte count and the associated clinical symptoms and complications
      • Subtype of the T-cell lineage, cytotoxic CD8 cells (Downey cells), contain eccentrically placed and lobulated nuclei with vacuolated cytoplasm: The “atypical lymphocytes” seen on differential
    • B-cell response:
      • EBV infects and replicates in B-cells
      • B-cells are then transformed into plasmacytoid cells that secrete immunoglobulins
      • IgM antibody secreted: The heterophile antibody which is reactive against red cell antigens
  • Mortality from IM is rare, but may occur due to the following complications:
    • Airway edema
    • Neurologic complications
    • Secondary bacterial infection
    • Splenic rupture
    • Hepatic failure
    • Myocarditis
  • EBV infection has also been strongly linked to African Burkitt lymphoma and nasopharyngeal carcinoma
Pediatric Considerations
  • In children <4 yr, infection with EBV is often asymptomatic
  • In children who do become symptomatic, there is propensity toward atypical presentations:
    • Neutropenia, pneumonia, and varied rashes
    • Mesenteric lymphadenopathy and splenomegaly can cause the illness to present with abdominal pain and be confused with appendicitis.
    • Infants and toddlers can present with only irritability and failure to thrive so must be considered when no other source can be identified
DIAGNOSIS
SIGNS AND SYMPTOMS
History
  • Typically an insidious onset over several days to weeks but may be abrupt onset
  • Prodromal fatigue, malaise, arthralgias, and myalgias with a biphasic or “waxing and waning” course
  • Prominent or “worst ever” sore throat and fever. Airway edema may be reported as difficulty breathing or respiratory distress.
  • Swollen lymph nodes
  • Headache
  • Significant abdominal pain is uncommon but when present should raise concern about marked splenic enlargement or splenic rupture.
  • Varied rashes can be seen in 18–34% of children and adolescents (not associated with antibiotics)
  • Administration of ampicillin or amoxicillin in patients with IM is associated with development of a rash
Physical-Exam
  • Malaise and/or fatigue (90–100%)
  • Pharyngitis (65–85%) and tonsillar enlargement
  • Fever (80–95%)
  • Eyelid edema (15–35%)
  • Symmetric tender lymphadenopathy (100%)
  • Hepatomegaly (15–25%)
  • Splenomegaly (50–60%)
  • Nonspecific rashes
  • Morbilliform rash can be seen if the patient has been given ampicillin or amoxicillin:
    • Typically develops 5–9 days after the onset of antibiotic therapy (should not be interpreted as a penicillin allergy)
  • Petechia can occur on the skin or at the junction between the hard and the soft palate.
  • Complications found on exam:
    • Airway compromise due to edema (1–5%)
    • Severe abdominal tenderness may be due to splenic rupture (may also cause referred pain to left shoulder)
    • Jaundice (∼5%) due to hepatitis or hepatic failure
      • Hepatitis is the most common complication
    • Neurologic findings consistent with:
      • Encephalitis or cerebellitis
      • Aseptic meningitis
      • Guillain–Barré syndrome
      • Optic neuritis
      • Bell palsy
  • Anemia (palor): May be due to hemolytic anemia, thrombocytopenia, agranulocytosis, hemophagocytic lymphohistiocytosis (HLH)
  • Orchitis
  • Neck tenderness and/or limited range of motion due to pain: Secondary bacterial soft tissue infection such as retropharyngeal or peritonsillar abscesses
  • Signs of shock: May be due to dehydration or a secondary anaerobic sepsis

Other books

Enchantment by Pati Nagle
Southampton Spectacular by M. C. Soutter
Tube Riders, The by Ward, Chris
The Treasure Box by Penelope Stokes
Own Her by Jenika Snow